Comparison tool

Compare peptides

Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.

Select up to three (1/3)

Comparison results

Attribute
CategoryMetabolic
Evidence gradeLimited
Also known as5-amino-1-methylquinolinium
MechanismInhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese adipose tissue. Blocking it raises intracellular NAD+ and SAM, increasing energy expenditure in fat cells.
Key benefitsReduced fat-cell size in rodent studies · Increased cellular NAD+ · Oral bioavailability — no injections
Side effectsInsomnia if dosed late · Mild GI upset · Unknown long-term profile
Half-lifeEstimated several hours
AdministrationOral capsule
Dosing overview50–150 mg once daily in the morning
StorageCool, dry place away from light
Legal statusSold as a research compound; not an approved drug or dietary supplement.

Dosing figures reflect published literature and commonly reported community protocols. They are informational only.

Head-to-head comparisons

Each comparison below is its own page with the full attribute table, key differences and shared attributes for that pairing. They are grouped by the category the compounds are indexed under.

GLP-1 receptor agonists

Direct comparisons between the incretin-based compounds most often searched against one another.

Recovery and tissue repair

Pairings between compounds indexed for healing, connective tissue and post-injury recovery.

Growth-hormone axis

Secretagogues and releasing peptides that act on growth-hormone signalling, compared with each other and with adjacent compounds.

Longevity and mitochondrial

Compounds indexed under longevity, cellular and mitochondrial function.

Cognitive and nootropic

Peptides indexed for cognition and mood-related use.

Sexual health

Melanocortin and related compounds indexed for sexual-health use.